⌘K

Home/Filings/4/0001209191-17-005317

4//SEC Filing

ALBIREO PHARMA, INC. 4

Accession 0001209191-17-005317

CIK 0001322505operating

View on SEC.gov Company Profile

Filed

Jan 23, 7:00 PM ET

Accepted

Jan 24, 5:23 PM ET

Size

5.5 KB

Accession

0001209191-17-005317

Insider Transaction Report

Form 4

Period: 2017-01-20

ALBIREO PHARMA, INC.ALBO

CFO and Treasurer

Transactions

Award
Stock Option (right to buy)
2017-01-20+20,000→ 20,000 total
Exercise: $19.19Exp: 2027-01-19→ Common Stock (20,000 underlying)

Footnotes (1)

[F1]This option will vest and become exercisable in equal installments on the last day of 16 consecutive calendar quarters beginning with March 31, 2017 and ending on December 31, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ALBIREO PHARMA, INC.

CIK 0001322505

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001322505

Filing Metadata

Form type: 4
Filed: Jan 23, 7:00 PM ET
Accepted: Jan 24, 5:23 PM ET
Size: 5.5 KB

View on SEC.gov